Log in with your email address username.


[Comment] Baricitinib for systemic lupus erythematosus

Despite improvements in diagnostics and therapy over the past few decades, diagnosis of systemic lupus erythematosus is still associated with significant mortality and severe burden. Belimumab is the only new drug licensed during the past 50 years for systemic lupus erythematosus; therefore, any success of a drug in the pipeline raises new hope for patients and the scientific community.